Physician profile
Conrad Cole
NPI 1700828464
$15,761.22
in general payments reported to CMS, 2019-2025
7 companies · $938 in 2025
The $938 reported for 2025 was more than what 81% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,460 · 2020: $4,280 · 2022: $369 · 2023: $51.50 · 2024: $663 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,362 · Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,362.00 |
| Food and Beverage | $290.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $9,391.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $4,769.19 | 2019-2023 | Gattex |
| Eli Lilly and Company | $800.00 | 2025 | Omvoh |
| Evoendo, INC | $562.00 | 2024 | |
| Alcresta Therapeutics, INC. | $138.04 | 2025 | Relizorb |
| Genzyme Corporation | $75.10 | 2024 | |
| Fresenius Kabi USA, LLC | $25.63 | 2024 | Smoflipid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.